หน้าแรก
ค้นหา
Dr. Vokes on Biomarker Selection in Head and Neck Cancer
No description available
แสดงข้อมูลเพิ่มเติม 1
Dr. Vokes on Biomarker Selection in Head and Neck Cancer
Dr. Vokes on Investigative Biomarkers of Response to Checkpoint Inhibitors in Cancer
Dr. Bauml Discusses Biomarkers in Head and Neck Cancer
Dr. Weiss on Biomarkers in Head and Neck Cancer
Elucidating novel biomarkers for head and neck cancers
PD-L1 and alternative biomarkers in head and neck cancer
Dr. Vokes on PARP Inhibitors for NSCLC
Dr. Zandburg on Biomarker Development in Head and Neck Cancer
Dr. Zandberg on Biomarker Development in Head and Neck Cancer
Dr Aparna Dhar | Biomarkers in Head & Neck Cancer
Dr. Vokes on the Standard of Care for Stage III NSCLC
Updates in Head and Neck Cancers: 2023 West Oncology
Patient Selection for Upfront Immunotherapy in NSCLC - O
Dr. Joshua M. Bauml on Pembrolizumab Versus Chemo in Head and Neck Cancers
Patient Selection for Nivolumab in HNSCC
Nivolumab-Related Efficacy and Toxicity in HNSCC Patients
Novel immunotherapy approaches in metastatic head and neck cancer
Salivary Biomarker Development for Pancreatic Cancer Detection, David Wong, DMD,DMsc
Dr. Burtness on Ongoing Trials of Immunotherapy in Head and Neck Cancer
Dr. Ciccolini on Dose Levels of Cetuximab in Head and Neck Cancer
